1. Home
  2. Stock quotes
  3. Stock Silverback Therapeutics
Silverback Therapeutics logo

Silverback Therapeutics SBTX

$ 6.1 4.99%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Country

 usaUSA

IPO year

 2020

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

CEO

 -

Employees in the company

 -

Shares

 95.2 M

Market Cap[1]

 $ 220 M

EBITDA (LTM)

 $ -71.4 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.